Alivus Life Sciences Acquires 9.21% Stake in Torrent Urja 19 Private Limited
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 07 Oct 2026, 05:16 PM IST · BSE ID: 7323fcf4-71a8-4dad-80ef-b47e1cba4f73
View Original BSE Filing (PDF)
💡
In Simple Terms
Alivus Life Sciences bought a 9.21% share in a solar energy company, investing Rs. 14.04 Crores to boost renewable power use.
🤖 AI Summary
- Alivus Life Sciences acquired a 9.21% stake in Torrent Urja 19 Private Limited for Rs. 14.04 Crores.
- Torrent Urja 19 Private Limited is a special purpose vehicle (SPV) focused on solar and renewable energy projects.
- The acquisition aligns with Alivus Life Sciences' commitment to achieve carbon neutrality by 2030.
- Investment qualifies Alivus Life Sciences as a captive user under Indian electricity laws.
- Promoter Nirma Limited also acquired a 16.99% stake in Torrent Urja 19 Private Limited.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Stake acquired in Torrent Urja 19 Private Limited
9.21%
Cost of acquisition (presently invested)
Rs. 14.04 Crores
Total planned investment (up to)
Rs. 16 Crores
Promoter Nirma Limited stake in Torrent Urja 19 Private Limited
16.99%
🏢 How This Affects the Company
This acquisition integrates renewable energy sources into Alivus Life Sciences' operations, supporting its carbon neutrality goal. It enables the company to meet regulatory requirements for captive power users.
Alivus Life Sciences has invested Rs. 14.04 Crores in equity for this 9.21% stake, contributing to a total planned investment of up to Rs. 16 Crores.
The investment in Torrent Urja 19 Private Limited will enhance the share of renewable power in Alivus Life Sciences' operations, potentially reducing reliance on traditional energy sources.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this acquisition update.
👤
Who Is Affected
Shareholders of Alivus Life Sciences are affected by the company's strategic capital deployment of Rs. 14.04 Crores towards a renewable energy asset, impacting the company's asset base.
🔍
Management Signal
Management is signaling a strategic commitment to renewable energy adoption and carbon neutrality, utilizing capital for environmental compliance and operational sustainability.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Future disclosures on Alivus Life Sciences' progress towards its 2030 carbon neutrality commitment.
Updates on the operational status and power generation from Torrent Urja 19 Private Limited.
Alivus Life Sciences' next financial results for further details on capital expenditure and energy sourcing.
LOW RISK
The filing reports a completed equity acquisition, not a speculative event. Associated risks are minimal as per the disclosure.
💡 Investor Takeaway
Alivus Life Sciences acquired a 9.21% stake in Torrent Urja 19 Private Limited for Rs. 14.04 Crores. This investment integrates renewable power, supporting Alivus's carbon neutrality target by 2030 and meeting captive user regulatory requirements under Indian electricity laws.
⚖️ Strengths & Concerns
✅ Positives
- The acquisition of a 9.21% stake supports Alivus Life Sciences' strategic commitment to become carbon neutral by 2030.
- Investment in Torrent Urja 19 Private Limited enables Alivus Life Sciences to comply with captive user regulatory requirements under Indian electricity laws.
⚠️ Concerns
- Torrent Urja 19 Private Limited reported Nil turnover as of 31st March 2026, indicating it is a newly established entity with no operational history.
- The investment of Rs. 14.04 Crores represents capital deployment into a newly formed special purpose vehicle.
📅 Company Track Record
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has announced its first acquisition after its name change. The company disclosed an earlier intimation regarding a Share Purchase cum Subscription Shareholders’ Agreement with Torrent Urja 19 Private Limited on April 2, 2025.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What stake did Alivus Life Sciences acquire in Torrent Urja 19 Private Limited?
Alivus Life Sciences acquired a 9.21% stake in Torrent Urja 19 Private Limited, investing Rs. 14.04 Crores in the entity.
What is the purpose of Alivus Life Sciences' acquisition in Torrent Urja 19 Private Limited?
The acquisition is in line with Alivus Life Sciences' commitment to become carbon neutral by 2030 and to comply with regulatory requirements for being a captive user under Indian electricity laws.
What is the business of Torrent Urja 19 Private Limited?
Torrent Urja 19 Private Limited is a special purpose vehicle (SPV) formed for setting up solar or other renewable energy projects, engaged in generating and transmitting solar and other renewable energy.
What was the turnover of Torrent Urja 19 Private Limited in the last three years?
Torrent Urja 19 Private Limited reported Nil turnover as of 31st March 2026, as it was incorporated on August 6, 2024.
Did Alivus Life Sciences' promoter, Nirma Limited, also invest in Torrent Urja 19 Private Limited?
Yes, Alivus Life Sciences' promoter, Nirma Limited, has also acquired a 16.99% stake in Torrent Urja 19 Private Limited through a similar Power Supply Agreement and Share Purchase cum Subscription Shareholders Agreement.
Questions based on this BSE filing only. For information purposes.